MedTrace Logo

Prenatal Screening, Diagnosis and Intrauterine Intervention of Fetal Abnormal Chromosome and Structure in Twins Pregnancy

NCT02982356 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1300

Last updated 2016-12-05

No results posted yet for this study

Summary

The risk of abnormal chromosome and structure is much higher in twins than in singletons, and traditional early pregnancy screening strategy for single pregnancy is not suitable for twins. Based on our management experience of fetal medicine at twin pregnancy, and multi-center cooperation, the study will carry out the following clinical studies:

1. to explore a suitable, early, noninvasive and accurate prenatal screening strategy for twin pregnancy.
2. fetal chromosomal abnormalities

Conditions

  • Chromosome Abnormality
  • Twin Pregnancy With Antenatal Problem

Interventions

PROCEDURE

Fetal Selective Reduction Technology

Fetal Selective Reduction Technology will be conducted according to different gestational weeks: before 16weeks, 16\~24 weeks, 24\~27+6 weeks,\>28weeks

DRUG

Potassium Chloride

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    collaborator OTHER

  • International Peace Maternity and Child Health Hospital

    collaborator OTHER

  • Shanghai First Maternity and Infant Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02982356 on ClinicalTrials.gov